GenMark's Q2 Revenues Grow 35 Percent

The company said that it will launch its Hepatitis C genotyping test this month and remains in discussions with FDA on tests for respiratory viruses, 2C19, and KRAS.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories